DOCSLIB.ORG

Research Article Antidepressant-Like Activity of the Ethanolic Extract from Uncaria Lanosa Wallich Var. Appendiculata Ridsd in T

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Research Article Antidepressant-Like Activity of the Ethanolic Extract from Uncaria Lanosa Wallich Var. Appendiculata Ridsd in T Hindawi Publishing Corporation Evidence-Based Complementary and Alternative Medicine Volume 2012, Article ID 497302, 12 pages doi:10.1155/2012/497302 Research Article Antidepressant-Like Activity of the Ethanolic Extract from Uncaria lanosa Wallich var. appendiculata Ridsd in the Forced Swimming Test and in the Tail Suspension Test in Mice Lieh-Ching Hsu,1 Yu-Jen Ko,1 Hao-Yuan Cheng,2 Ching-Wen Chang,1 Yu-Chin Lin,3 Ying-Hui Cheng,1 Ming-Tsuen Hsieh,1 and Wen Huang Peng1 1 School of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, College of Pharmacy, China Medical University, No. 91 Hsueh-Shih Road, Taichung 404, Taiwan 2 Department of Nursing, Chung Jen College of Nursing, Health Sciences and Management, No. 1-10 Da-Hu, Hu-Bei Village, Da-Lin Township, Chia-Yi 62241, Taiwan 3 Department of Biotechnology, TransWorld University, No. 1221, Jen-Nang Road, Chia-Tong Li, Douliou, Yunlin 64063, Taiwan Correspondence should be addressed to Hao-Yuan Cheng, [email protected] and Wen Huang Peng, [email protected] Received 23 November 2011; Revised 30 January 2012; Accepted 30 January 2012 Academic Editor: Vincenzo De Feo Copyright © 2012 Lieh-Ching Hsu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. This study investigated the antidepressant activity of ethanolic extract of U. lanosa Wallich var. appendiculata Ridsd (ULEtOH)for two-weeks administrations by using FST and TST on mice. In order to understand the probable mechanism of antidepressant-like activity of ULEtOH in FST and TST, the researchers measured the levels of monoamines and monoamine oxidase activities in mice brain, and combined the antidepressant drugs (fluoxetine, imipramine, maprotiline, clorgyline, bupropion and ketanserin). Lastly, the researchers analyzed the content of RHY in the ULEtOH. The results showed that ULEtOH exhibited antidepressant-like activity in FSTandTSTinmice.ULEtOH increased the levels of 5-HT and 5-HIAA in cortex, striatum, hippocampus, and hypothalamus, the levels of NE and MHPG in cortex and hippocampus, the level of NE in striatum, and the level of DOPAC in striatum. Two-week injection of IMI, CLO, FLU and KET enhanced the antidepressant-like activity of ULEtOH.ULEtOH inhibited the activity of MAO- A. The amount of RHY in ULEtOH was 17.12 mg/g extract. Our findings support the view that ULEtOH exerts antidepressant-like activity. The antidepressant-like mechanism of ULEtOH may be related to the increase in monoamines levels in the hippocampus, cortex, striatum, and hypothalamus of mice. 1. Introduction serotonin reuptake inhibitors (SSRIs), monoamine oxi- dase inhibitors (MAOIs), specific serotonin-norepinephrine Depression, a widespread incapacitating psychiatric ailment, reuptake inhibitors (SNRIs), 5-HT2 receptor antagonists, imposes a substantial health burden on society [1]. Affec- and other heterocyclics are clinically employed for drug tive disorder are characterized by a disturbance of mood therapy [5]. However, these drugs can impose a variety associated with alteration in behavior, energy, appetite, of side-effects including sedation, apathy, fatigue, sleep sleep, and weight [2]. According to the most accepted hy- disturbance, cognitive impairment, and sexual dysfunction, pothesis of depression, the monoamine theory, patients and so forth. Hence, there remains a pressing need for new with major depression have symptoms that are reflected effective and better-tolerated antidepressants. changes in brain monoamine neurotransmitters, specifically Herbal therapies may be effective alternatives in the norepinephrine (NE) and serotonin (5-HT) [3]. Clinical treatment of depression, such as HypericumperforatumL. data suggests that dopamine (DA) is also involved in [6], Cordyceps sinensis [7], and Perilla frutescens [8]. The the pathophysiology and treatment of depression [4]. Med- Uncaria species recorded in Chinese Pharmacopoeia and Tai- ications such as tricyclic antidepressants (TCAs), selective wan Herbal Pharmacopoeia include Uncaria rhynchophylla 2 Evidence-Based Complementary and Alternative Medicine (Miquel) Jacks (abbrev. as UR), U. macrophylla Wallich. U. Animals. The experimental protocol was approved by the hirsuta Haviland (UH), U. sinensis (Oliver) Havil, and U. Committee on Animal Research, China Medical University. sessilifructus Roxburgh [9, 10]. According to Flora of Taiwan, The minimum number of animals and duration of observa- there are three different species of Gouteng in Taiwan: UR, tions required to obtain consistent data were used. UH, and U. lanosa Wallich var.appendiculataRidsd (UL) [11]. However, UL is not recorded in Pharmacopoeia. In 2.2. Plant Materials. Uncaria rhynchophylla (Miquel) Jacks traditional Chinese medicine, Gouteng is categorized as a (UR) was collected from SiaoWulai, U. hirsuta Haviland herb to extinguish wind, arrest convulsions, clear heat, and (UH) was collected from Wulai, and U. lanosa Wallich pacify the liver [12]. Gouteng is mainly used to treat cardio- var.appendiculataRidsd (UL) was collected from Xuhai, vascular and central nervous system ailments, including light Mudan Township of Taiwan, and was identified by Dr. Chao- headedness, convulsions, numbness, and hypertension [12]. Lin Kuo, Leader of the School of Chinese Pharmaceutical Several studies demonstrate that the herb extract mainly acts Sciences and Chinese Medicine Resources (CPCR). The ff on neuroprotective e ect used to treat antiepileptic [13–15], voucher specimen (Number: CMU-CPCR-UL-10001) was anti-Parkinsonian [16], anti-Alzheimer’s disease [17, 18], deposited at CPCR. anxiolytic [19], protective action against ischemia-induced neuronal damage [20, 21], anti-inflammation [22]. Alkaloids 2.3. Preparation of Plant Extract. Dried 1 kg of UR, UH, and are the active pharmacological component in Gouteng and UL, made from the stems and hooks of plants, were sliced comprise components include RHY, isorhynchophylline, into small pieces and ground into a powder, and extracted hirsutine, hirsuteine, corynantheine, isocorynoxeine. RHY four times with 5% ammonia solution and 70% ethanol. The exhibited a similar pharmacological activity when compared extracts were filtered, combined, and concentrated under with Gouteng [12]. RHY is an important active compo- reduced pressure at 40◦C to obtain the UR ,UH , nent of alkaloids separated from gambir plant (Gouteng EtOH EtOH UL extracts. The yield ratios of the UR ,UH , in Chinese), RHY exerts the protective action primarily EtOH EtOH EtOH ULEtOH extracts (120 g, 97 g, 115 g) were 12%, 9.7%, 11.5%. by inhibiting of NMDA and 5-HT2 receptor-mediated neurotoxicity during ischemia [21]. RHY also affects the levels of serotonin in cortex, striatum, hippocampus, and 2.4. Drugs and Drug Administration. Imipramine HCl (IMI), hypothalamus [23, 24]. From the above perspectives, we clorgyline HCl (CLO), maprotiline HCl (MAP), fluoxe- inferred that RHY is the key component of antidepressant- tine HCl(FLU), bupropion HCl (BUP), ketanserin (KET), like activity of Gouteng. Gouteng possesses neuroprotective sodium octyl sulfate, norepinephrine HCl (NE), dopamine effect, regulation of monoamine transporters, macrophage HCl (DA), 5-hydroxytryptamine HCl (5-HT), 4-Hydroxy- theory [25], and regulation of glutamatergic system [26]. 3-methoxyphenylglycol (MHPG), 4-dihydroxyphenylacetic Our preliminary test indicated that ethanolic extract of U. acid (DOPAC), and 5-hydroxyindoleacetic acid (5-HIAA), as lanosa Wallich var.appendiculataRidsd. (UL ) contained well as horseradish peroxidase (HRP), benzylamine, amplex EtOH ff the largest amount of RHY among Uncaria species in Taiwan. red, and phosphate-bu ered saline (PBS) solution were purchased from Sigma-Aldorich (St. Louis, MO, USA). RHY However, the antidepressant-like activity of ULEtOH has not been investigated, which encouraged us to investigate the was purchased from Matsuura Yakugyo Co., Ltd (Japan). Drugs were dissolved in normal saline, except HRP, benzy- effects of ULEtOH on depression problems. lamine, and amplex red that was diluted in PBS solution. In the present study, we aimed to investigate the effect Citric acid, tri-natriumcitrate-2-hydrate, and EDTA were of UL in FST and TST in mice. The behavioral despair EtOH purchased from Merck. UR ,UH ,UL , or saline tasks have good predictive value for antidepressant potency EtOH EtOH EtOH ff was administered by oral route, whereas the other drugs were in humans [27]. Moreover, we investigated whether the e ect administered by i.p. route. The i.p. or p.o. administrations of ULEtOH in FST and TST is dependent on its interaction were given in a volume of 10 mL/kg body weight. Tests with the 5-HT, NE, and DA receptors, and the brain were performed 1 hr (ULEtOH) and 30 min (imipramine, monoamine neurotransmitter concentration. MAO activity fluoxetine, clorgyline, maprotiline, bupropion, ketanserin) was also tested by neurochemical and biochemical assays after administration. to confirm the participation of monoamine transmitters in treatment involving ULEtOH. 2.5. HPLC Analysis of UREtOH,UHEtOH,andULEtOH. The HPLC system consisted of a Shimadzu (Kyoto, Japan) LC- 2. Materials and Methods 10ATvp liquid chromatograph equipped with a DGU-14A degasser, an FCV-10ALvp low-pressure gradient flow control 2.1. Animals. Male ICR albino mice (weighing around 22 g), valve, an SIL-10ADvp autoinjector, an SPD-M10Avp diode purchased from BioLASCO
Load more

Recommended publications
  • Rhynchophylline Loaded-Mpeg-PLGA Nanoparticles Coated with Tween-80 for Preliminary Study in Alzheimer's Disease
    International Journal of Nanomedicine Dovepress open access to scientific and medical research Open Access Full Text Article ORIGINAL RESEARCH Rhynchophylline Loaded-mPEG-PLGA Nanoparticles Coated with Tween-80 for Preliminary Study in Alzheimer’sDisease This article was published in the following Dove Press journal: International Journal of Nanomedicine Ruiling Xu1 Purpose: Alzheimer’s disease (AD) is a growing concern in the modern society. The current Junying Wang1 drugs approved by FDA are not very promising. Rhynchophylline (RIN) is a major active Juanjuan Xu1 tetracyclic oxindole alkaloid stem from traditional Chinese medicine uncaria species, which fi Xiangrong Song2 has potential activities bene cial for the treatment of AD. However, the application of Hai Huang 2 rhynchophylline for AD treatment is restricted by the low water solubility, low concentration in brain tissue and low bioavailability. And there is no study of brain-targeting therapy with Yue Feng 3 RIN. In this work, we prepared rhynchophylline loaded methoxy poly (ethylene glycol)–poly Chunmei Fu1 (dl-lactide-co-glycolic acid) (mPEG-PLGA) nanoparticles (NPS-RIN), which coupled with 1Key Laboratory of Drug-Targeting and Tween 80 (T80) further for brain targeting delivery (T80-NPS-RIN). Drug Delivery System of the Education Methods: Preparation and characterization of T80-NPS-RIN were followed by the detection Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced of transportation across the blood–brain barrier (BBB) model in vitro, biodistribution and Drug and Sichuan Research Center for neuroprotective effects of nanoparticles. Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan Results: The results indicated T80-NPS-RIN could usefully assist RIN to pass through the University, Chengdu 610041, People’s BBB to the brain.
    [Show full text]
  • European Chemistry Congress June 16-18, 2016 Rome, Italy
    conferenceseries.com conferenceseries.com 513th Conference European Chemistry Congress June 16-18, 2016 Rome, Italy Posters Page 98 Adriana A Lopes et al., Chem Sci J 2016, 7:2(Suppl) http://dx.doi.org/10.4172/2150-3494.C1.003 conferenceseries.com European Chemistry Congress June 16-18, 2016 Rome, Italy Unnatural fluoro-oxindole alkaloids produced by Uncaria guianensis plantlets Adriana A Lopes, Bruno Musquiari, Suzelei de C França and Ana Maria S Pereira Universidade de Ribeirão Preto, Brazil atural products and their analogues have been sources of numerous important therapeutic agents. The medicinal plant NU. guianensis (Rubiaceae) cultured in vitro produce four oxindole alkaloids that displays anti-tumoral activity. Natural products can be modified by several approaches, one of which is precursor-directed biosynthesis (PDB). Thus, the aim of this work was apply precursor-directed biosynthesis approach to obtain oxindole alkaloids analogues using in vitro Uncaria guianensis. Plantletes were cultivated into culture medium supplemented with 1mM of 6-fluoro-tryptamine, the indol precursor of alkaloids biosynthesis. U. guianensis explants were maintained at 25±2°C, 55-60% relative humidity under the same photoperiod and light intensity. After 30 days, a methanolic extract from U. guianensis was obtained and analysed by HPLC- DAD analytical procedure. The chromatogram showed four natural alkaloids (mitraphylline, isomitraphylline, rhynchophylline and isorhynchophylline and four additional peaks. Semi-preparative HPLC allowed isolation and purification of these four oxindole alkaloids analogues and the identity of the peaks was confirmed from high-resolution MS data (HRESIMS/MS in positive mode). All data confirmed that Uncaria guianensis produced fluoro-oxindole alkaloids analogues.
    [Show full text]
  • Ep 1553091 A1
    Europäisches Patentamt *EP001553091A1* (19) European Patent Office Office européen des brevets (11) EP 1 553 091 A1 (12) EUROPEAN PATENT APPLICATION published in accordance with Art. 158(3) EPC (43) Date of publication: (51) Int Cl.7: C07D 263/32, C07D 417/14, 13.07.2005 Bulletin 2005/28 C07D 333/20, C07D 413/12, C07D 417/06 (21) Application number: 04726765.3 (86) International application number: (22) Date of filing: 09.04.2004 PCT/JP2004/005119 (87) International publication number: WO 2004/089918 (21.10.2004 Gazette 2004/43) (84) Designated Contracting States: • SAKAMOTO, Johei AT BE BG CH CY CZ DE DK EE ES FI FR GB GR Takatsuki-shi, Osaka 569-1125 (JP) HU IE IT LI LU MC NL PL PT RO SE SI SK TR • NAKANISHI, Hiroyuki Designated Extension States: Takatsuki-shi, Osaka 569-1125 (JP) AL HR LT LV MK • NAKAGAWA, Yuichi Takatsuki-shi, Osaka 569-1125 (JP) (30) Priority: 09.04.2003 JP 2003105267 • OHTA, Takeshi 03.06.2003 JP 2003157590 Takatsuki-shi, Osaka 569-1125 (JP) • SAKATA, Shohei (71) Applicant: Japan Tobacco Inc. Takatsuki-shi, Osaka 569-1125 (JP) Tokyo 105-8422 (JP) • MORINAGA, Hisayo Takatsuki-shi, Osaka 569-1125 (JP) (72) Inventors: • IKEMOTO, Tomoyuki (74) Representative: Takatsuki-shi, Osaka 569-1125 (JP) von Kreisler, Alek, Dipl.-Chem. et al • TANAKA, Masahiro Deichmannhaus am Dom, Takatsuki-shi, Osaka 569-1125 (JP) Postfach 10 22 41 • YUNO, Takeo 50462 Köln (DE) Takatsuki-shi, Osaka 569-1125 (JP) (54) HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF (57) A 5-membered heteroaromatic ring compound represented by the formula [I] 1 2 4 5 7 wherein V is CH or N; W is S or O; R and R are each H etc.; X is -N(R )-, -O-, -S-, -SO2-N(R )-, -CO-N(R )- etc.; L is EP 1 553 091 A1 Printed by Jouve, 75001 PARIS (FR) (Cont.
    [Show full text]
  • Full-Text (PDF)
    Review ARticle دوره هفتم، شماره سوم، تابستان 1398 دوره هفتم، شماره سوم، تابستان 1398 Review on the Third International Neuroinflammation Congress and Student Fes tival of Neuroscience in Mashhad University of Medical Sciences 1 2 1, 3* Sayed Mos tafa Modarres Mousavi , Sajad Sahab Negah , Ali Gorji 1Shefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, Iran 2Department of Neuroscience, Mashhad University of Medical Sciences, Mashhad, Iran 3 Epilepsy Research Center, Department of Neurology and Neurosurgery, Wes tfälische Wilhelms-Universität Müns ter, Müns ter, Germany Article Info: Received: 11 June 2019 Revised: 12 June 2019 Accepted: 13 June 2019 ABSTRACT Introduction: Neuroinflammation congress was the third in a series of annual events aimed to facilitate the inves tigative and analytical discussions on a range of neuroinflammatory diseases. The neuroinflammation congress focused on various neuroinflammatory disorders, including multiple sclerosis, brain tumors, epilepsy, and neurodegenerative diseases. The conference was held in June 11-13, 2019 and organized by Mashhad University of Medical Sciences and Muns ter University, which aimed to shed light on the causes of neuroinflammatory diseases and uncover new treatment pathways. Conclusion: Through a comprehensive scientific program with a broad basic and clinical aspects, we discussed the basic aspects of neuroinflammation and neurodegeneration up to the s tate-of-the-art treatments. In this congress, 334 scientific topics were presented and discussed. Key words:
    [Show full text]
  • 7Th World Congress on ADHD: from Child to Adult Disorder
    ADHD Atten Def Hyp Disord (2019) 11(Suppl 1):S1–S89 https://doi.org/10.1007/s12402-019-00295-7 ABSTRACTS Ó Springer-Verlag GmbH Austria, part of Springer Nature 2019 7th World Congress on ADHD: From Child to Adult Disorder 25th–28th April, Lisbon Portugal Editors: Manfred Gerlach, Wu¨rzburg Peter Riederer, Wu¨rzburg Andreas Warnke, Wu¨rzburg Luis Rohde, Porto Alegre 123 S2 ABSTRACTS Introduction Dear Colleagues and Friends, We are pleased to have received more than 180 poster abstracts as well as more than 100 poster abstracts from young scientists and clinicians (\ 35 years) who applied for our Young Scientists’ Award. Of all abstracts submitted by our young colleagues, the Scientific Programme Committee has selected the best eight. The authors have been invited to give a presentation as part of our two Young Scientist Award Sessions and to receive a prize money in the amount of 500 Euros. With this approach, we intend to highlight the importance of original scientific contributions, especially from our young colleagues. In this volume, the abstracts of our two Young Scientist Award Sessions come first, followed by regular poster abstracts. These have been organized by topics: Aetiology, Autism Spectrum Disorders, Co-morbidity, Diagnosis, Electrophysiology, Epidemiology, Experimental Models, Genetics, Neuroimaging, Non-pharmacological Treatment, Pathophysiology, Pharmacological Treatment, Quality of Life/Caregiver Burden, Substance Use Disorders and Miscellaneous. Submitted abstracts have not been modified in any way. Please, do not just read the selected poster abstracts, we also encourage you to actively discuss and share your ideas with our young colleagues. Finally, we would like thank all our speakers, contributors and sponsors of our 7th World Congress on ADHD: from Childhood to Adult Disease, and welcome you to join—what we are sure will be—a very enjoyable and highly informative event.
    [Show full text]
  • World of Cognitive Enhancers
    ORIGINAL RESEARCH published: 11 September 2020 doi: 10.3389/fpsyt.2020.546796 The Psychonauts’ World of Cognitive Enhancers Flavia Napoletano 1,2, Fabrizio Schifano 2*, John Martin Corkery 2, Amira Guirguis 2,3, Davide Arillotta 2,4, Caroline Zangani 2,5 and Alessandro Vento 6,7,8 1 Department of Mental Health, Homerton University Hospital, East London Foundation Trust, London, United Kingdom, 2 Psychopharmacology, Drug Misuse, and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom, 3 Swansea University Medical School, Institute of Life Sciences 2, Swansea University, Swansea, United Kingdom, 4 Psychiatry Unit, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy, 5 Department of Health Sciences, University of Milan, Milan, Italy, 6 Department of Mental Health, Addictions’ Observatory (ODDPSS), Rome, Italy, 7 Department of Mental Health, Guglielmo Marconi” University, Rome, Italy, 8 Department of Mental Health, ASL Roma 2, Rome, Italy Background: There is growing availability of novel psychoactive substances (NPS), including cognitive enhancers (CEs) which can be used in the treatment of certain mental health disorders. While treating cognitive deficit symptoms in neuropsychiatric or neurodegenerative disorders using CEs might have significant benefits for patients, the increasing recreational use of these substances by healthy individuals raises many clinical, medico-legal, and ethical issues. Moreover, it has become very challenging for clinicians to Edited by: keep up-to-date with CEs currently available as comprehensive official lists do not exist. Simona Pichini, Methods: Using a web crawler (NPSfinder®), the present study aimed at assessing National Institute of Health (ISS), Italy Reviewed by: psychonaut fora/platforms to better understand the online situation regarding CEs.
    [Show full text]
  • Research Article Pharmacokinetic Interaction Study of Ketamine and Rhynchophylline in Rat Plasma by Ultra-Performance Liquid Chromatography Tandem Mass Spectrometry
    Hindawi BioMed Research International Volume 2018, Article ID 6562309, 8 pages https://doi.org/10.1155/2018/6562309 Research Article Pharmacokinetic Interaction Study of Ketamine and Rhynchophylline in Rat Plasma by Ultra-Performance Liquid Chromatography Tandem Mass Spectrometry Lianguo Chen,1 Weiwei You,1 Dingwen Chen,1 Yuan Cai,1 Xianqin Wang ,2 Congcong Wen ,3 and Bo Wu 3 1 Te Tird Clinical Institute Afliated to Wenzhou Medical University & Wenzhou People’s Hospital, Wenzhou 325000, China 2Analytical and Testing Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China 3Laboratory Animal Centre, Wenzhou Medical University, Wenzhou, China Correspondence should be addressed to Congcong Wen; [email protected] and Bo Wu; [email protected] Received 7 March 2018; Accepted 11 April 2018; Published 23 May 2018 Academic Editor: Gail B. Mahady Copyright © 2018 Lianguo Chen et al. Tis is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Eighteen Sprague-Dawley rats were randomly divided into three groups: ketamine group, rhynchophylline group, and ketamine combined with rhynchophylline group (n = 6). Te rats of two groups received a single intraperitoneal administration of 30 mg/kg ketamine and 30 mg/kg rhynchophylline, respectively, and the third group received combined intraperitoneal administration of 30 mg/kg ketamine and 30 mg/kg rhynchophylline together. Afer blood sampling at diferent time points and processing, the concentrations of ketamine and rhynchophylline in rat plasma were determined by the established ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method.
    [Show full text]
  • Cns Active Principles from Selected Chinese Medicinal Plants
    THE FACULTY OF MEDICINE IN THE UNIVERSITY OF LONDON CNS ACTIVE PRINCIPLES FROM SELECTED CHINESE MEDICINAL PLANTS Thesis presented by MIN ZHU (BSc., MSc.) for the degree of Doctor of Philosophy Department of Pharmacognosy The School of Pharmacy University of London 1994 ProQuest Number: 10105154 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest. ProQuest 10105154 Published by ProQuest LLC(2016). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States Code. Microform Edition © ProQuest LLC. ProQuest LLC 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106-1346 ABSTRACT In order to identify potential central nervous system (CNS) active principles from plants, 10 Chinese herbs have been selected from literature reports, namely Schejflera hodinieri, Schejflera delavayi, Celastrus angulatus, Celastrus orbiculatus, Clerodendrum mandarinorum, Clerodendrum bungei, Periploca callophylla, Periploca forrestii, Alangium plantanifolium and Uncaria rhynchophylla. These plants were extracted by 70% ethanol and biologically screened by receptor ligand binding assays which included a 1-adrenoceptor, a2-adrenoceptor, p-adrenoceptor, 5HT1, 5HT1A, 5HT1C, 5HT2, opiate, benzodiazepine, Ca^-ion channel(DHP), K^-ion channel, dopamine 1, dopamine 2, adenosine 1, muscarinic, histamine 1, Na'^/K^ ATPase, GABA^ and GABAg receptors. The results of extract screening showed that all these plants were able to inhibit the specific binding of radioligands to at least one receptor at concentrations of 1 mg/ml.
    [Show full text]
  • Lessons Learned
    Prevention and Reversal of Chronic Disease Copyright © 2019 RN Kostoff PREVENTION AND REVERSAL OF CHRONIC DISEASE: LESSONS LEARNED By Ronald N. Kostoff, Ph.D., School of Public Policy, Georgia Institute of Technology 13500 Tallyrand Way, Gainesville, VA, 20155 [email protected] KEYWORDS Chronic disease prevention; chronic disease reversal; chronic kidney disease; Alzheimer’s Disease; peripheral neuropathy; peripheral arterial disease; contributing factors; treatments; biomarkers; literature-based discovery; text mining ABSTRACT For a decade, our research group has been developing protocols to prevent and reverse chronic diseases. The present monograph outlines the lessons we have learned from both conducting the studies and identifying common patterns in the results. The main product of our studies is a five-step treatment protocol to reverse any chronic disease, based on the following systemic medical principle: at the present time, removal of cause is a necessary, but not necessarily sufficient, condition for restorative treatment to be effective. Implementation of the five-step treatment protocol is as follows: FIVE-STEP TREATMENT PROTOCOL TO REVERSE ANY CHRONIC DISEASE Step 1: Obtain a detailed medical and habit/exposure history from the patient. Step 2: Administer written and clinical performance and behavioral tests to assess the severity of symptoms and performance measures. Step 3: Administer laboratory tests (blood, urine, imaging, etc) Step 4: Eliminate ongoing contributing factors to the chronic disease Step 5: Implement treatments for the chronic disease This individually-tailored chronic disease treatment protocol can be implemented with the data available in the biomedical literature now. It is general and applicable to any chronic disease that has an associated substantial research literature (with the possible exceptions of individuals with strong genetic predispositions to the disease in question or who have suffered irreversible damage from the disease).
    [Show full text]
  • Pharmacologyonline 3: 856-861 (2006) Zhi Xian Mo Et Al
    Pharmacologyonline 3: 856-861 (2006) Zhi Xian Mo et al. EFFECTS OF RHYNCHOPHYLLINE ON RAT CORTICAL NEURONS STRESSED BY METHAMPHETAMINE Zhi Xian Mo1*, Dan Dan Xu1, Ken Kin Lam Yung2 1 School of Chinese Medicine, Southern Medical University, Guangzhou, China 2 Department of Biology, Hong Kong Baptist University, Kowloon Tong, Hong Kong, China *Corresponding author: E-mail: [email protected] Summary Objective: To reveal the neurotoxicity of Methamphetamine (MA) on cortical neurons in rats and to study the protective effects of Rhynchophylline (Rhy) on MA treated neurons. Methods: The neurotoxicity of MA was measured with MTT assay in primary cultured cortical neurons. The viability of neurons treated MA for 48 h combined with Rhy or ketamine was also tested. Results: MTT assay showed that MA had a nurotoxicity on rat cortical neurons and Rhy could protect against MA in culture viability. Conclusion: Rhy shows neuroprotective effect against MA in vitro. This property may also contribute to the neural activity of the origin of Uncaria species plants. These results suggest rhynchophylline may benefit for the treatment of MA exposure. Key words: methamphetamine; rhynchophylline; ketamine; psychologic dependence; MTT assay Methamphetamine (MA) is a abused psychostimulant. Repeated drug administration produces many changes of the brain functions. N-methyl-D-aspartate (NMDA) receptor, a kind of ionotropic glutamate receptor, is involved in mediating biological actions of the drug abuse, especially the psychostimulants (1). It was reported that MA appears to have a toxic effect on the neurons with a long-time exposure (2). In the present study, the neurotoxicity of MA was examined in cortical neurons which were abundant with NMDA receptors.
    [Show full text]
  • WO 2015/069669 Al 14 May 2015 (14.05.2015) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2015/069669 Al 14 May 2015 (14.05.2015) P O P C T (51) International Patent Classification: DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, A61K 47/48 (2006.01) B82Y 5/00 (201 1.01) HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, A61P 21/00 (2006.01) A61K 9/00 (2006.01) KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, (21) International Application Number: PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, PCT/US2014/063963 SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, (22) International Filing Date: TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. 4 November 2014 (04.1 1.2014) (84) Designated States (unless otherwise indicated, for every (25) Filing Language: English kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, (26) Publication Language: English TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, (30) Priority Data: TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, 61/962,335 5 November 2013 (05. 11.2013) US DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, (72) Inventor; and SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, (71) Applicant : MOLOKANOVA, Elena [US/US]; 309, GW, KM, ML, MR, NE, SN, TD, TG).
    [Show full text]
  • Physical Electrochemistry Organizer: Daniel Scherson Case Western Reserve University, Cleveland, OH Organizer: Kenneth W
    Physical Electrochemistry Organizer: Daniel Scherson Case Western Reserve University, Cleveland, OH Organizer: Kenneth W. Street The NASA-Glenn Research Center, Cleveland, OH Presider: Daniel Scherson Case Western Reserve University, Cleveland, OH Session Overview: This session is devoted to all aspects of physical electrochemistry including electrocatalytic phenomena, corrosion, semiconductor electrochemistry and other topics. 1. Multiwalled Carbon Nanotube (MWCNT) as Support for PtRu Anode Catalysts of a Direct Ethanol Fuel Cell (DEFC) Susmita Singh and Jayati Datta, Department of Chemistry, Bengal Engg Sci University, Shibpur, Howrah, India DEFC is one of the most promising power sources for the near future. Since the kinetics and electro- efficiency of the process strongly depend on the noble metal formulations and their dispersion on suitable support, an intensive research is devoted to decrease the catalyst loading. This work reports an improved electro-catalytic activity for ethanol oxidation at Pt-Ru co-deposited surfaces on MWCNT support. Pt-Ru catalysts with different compositions were synthesized on pre- functionalized MWCNT by adopting sol method. The degree of surface functionalization is found to depend on the level of acid treatment. Chemical reduction of precursor salt using ethylene glycol as mild reducing agent as well as capping agent at 1400C yields catalyst particle size of few nanometers as confirmed by XRD and TEM studies. Cyclic voltammetry, polarization study and electrochemical impedance spectroscopy were employed to evaluate the electro-catalytic phenomenon over a range of H2SO4 and ethanol concentrations. A spectacular negative potential shift of more than 250 mV of the onset of ethanol oxidation was observed on the Pt-Ru catalyst in comparison to Pt alone.
    [Show full text]